Legal & General Group’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $665M | Sell |
10,600,766
-275,851
| -3% | -$22.1M | 0.15% | 120 |
|
|
2025
Q4 | $1.04B | Buy |
10,876,617
+419,442
| +4% | +$41.1M | 0.23% | 77 |
|
|
2025
Q3 | $1.02B | Buy |
10,457,175
+463,889
| +5% | +$48M | 0.23% | 80 |
|
|
2025
Q2 | $1.07B | Sell |
9,993,286
-874,798
| -8% | -$88.5M | 0.27% | 64 |
|
|
2025
Q1 | $1.1B | Buy |
10,868,084
+129,278
| +1% | +$13M | 0.3% | 56 |
|
|
2024
Q4 | $959M | Sell |
10,738,806
-399,753
| -4% | -$35.2M | 0.25% | 64 |
|
|
2024
Q3 | $933M | Sell |
11,138,559
-255,140
| -2% | -$20.1M | 0.25% | 70 |
|
|
2024
Q2 | $877M | Sell |
11,393,699
-25,761
| -0.2% | -$1.89M | 0.25% | 72 |
|
|
2024
Q1 | $782M | Buy |
11,419,460
+44,544
| +0.4% | +$2.86M | 0.23% | 85 |
|
|
2023
Q4 | $658M | Buy |
11,374,916
+121,548
| +1% | +$6.49M | 0.2% | 102 |
|
|
2023
Q3 | $594M | Sell |
11,253,368
-251,576
| -2% | -$13.2M | 0.21% | 97 |
|
|
2023
Q2 | $622M | Buy |
11,504,944
+742,518
| +7% | +$38.8M | 0.2% | 100 |
|
|
2023
Q1 | $538M | Buy |
10,762,426
+236,481
| +2% | +$11.1M | 0.19% | 110 |
|
|
2022
Q4 | $487M | Sell |
10,525,945
-319,607
| -3% | -$13.8M | 0.19% | 122 |
|
|
2022
Q3 | $420M | Sell |
10,845,552
-320,625
| -3% | -$12.9M | 0.16% | 127 |
|
|
2022
Q2 | $416M | Buy |
11,166,177
+409,391
| +4% | +$16.7M | 0.15% | 146 |
|
|
2022
Q1 | $476M | Buy |
10,756,786
+880,914
| +9% | +$38.2M | 0.14% | 141 |
|
|
2021
Q4 | $420M | Sell |
9,875,872
-398,544
| -4% | -$16.7M | 0.13% | 172 |
|
|
2021
Q3 | $446M | Buy |
10,274,416
+551,217
| +6% | +$24.4M | 0.14% | 146 |
|
|
2021
Q2 | $416M | Buy |
9,723,199
+541,219
| +6% | +$22.8M | 0.14% | 155 |
|
|
2021
Q1 | $355M | Sell |
9,181,980
-110,300
| -1% | -$4.17M | 0.13% | 166 |
|
|
2020
Q4 | $334M | Buy |
9,292,280
+237,625
| +3% | +$8.56M | 0.13% | 167 |
|
|
2020
Q3 | $346M | Sell |
9,054,655
-17,785
| -0.2% | -$685K | 0.15% | 144 |
|
|
2020
Q2 | $319M | Sell |
9,072,440
-96,545
| -1% | -$3.48M | 0.15% | 144 |
|
|
2020
Q1 | $300M | Buy |
9,168,985
+387,556
| +4% | +$15.1M | 0.18% | 132 |
|
|
2019
Q4 | $397M | Buy |
8,781,429
+226,587
| +3% | +$9.48M | 0.19% | 118 |
|
|
2019
Q3 | $348M | Sell |
8,554,842
-33,425
| -0.4% | -$1.42M | 0.18% | 124 |
|
|
2019
Q2 | $369M | Buy |
8,588,267
+17,999
| +0.2% | +$692K | 0.2% | 107 |
|
|
2019
Q1 | $329M | Buy |
8,570,268
+1,567,394
| +22% | +$59.9M | 0.19% | 116 |
|
|
2018
Q4 | $247M | Buy |
7,002,874
+598,647
| +9% | +$21.7M | 0.19% | 114 |
|
|
2018
Q3 | $247M | Buy |
6,404,227
+280,645
| +5% | +$9.8M | 0.18% | 130 |
|
|
2018
Q2 | $200M | Sell |
6,123,582
-260,671
| -4% | -$7.86M | 0.15% | 153 |
|
|
2018
Q1 | $174M | Sell |
6,384,253
-294,307
| -4% | -$8M | 0.13% | 182 |
|
|
2017
Q4 | $166M | Sell |
6,678,560
-82,438
| -1% | -$2.27M | 0.12% | 203 |
|
|
2017
Q3 | $197M | Buy |
6,760,998
+232,309
| +4% | +$6.42M | 0.15% | 169 |
|
|
2017
Q2 | $181M | Buy |
6,528,689
+163,465
| +3% | +$4.34M | 0.15% | 173 |
|
|
2017
Q1 | $158M | Buy |
6,365,224
+233,391
| +4% | +$5.68M | 0.13% | 182 |
|
|
2016
Q4 | $133M | Sell |
6,131,833
-90,557
| -1% | -$1.98M | 0.12% | 194 |
|
|
2016
Q3 | $148M | Buy |
6,222,390
+42,211
| +0.7% | +$1.01M | 0.15% | 162 |
|
|
2016
Q2 | $144M | Buy |
6,180,179
+267,960
| +5% | +$5.8M | 0.15% | 159 |
|
|
2016
Q1 | $111M | Buy |
5,912,219
+34,936
| +0.6% | +$614K | 0.12% | 190 |
|
|
2015
Q4 | $108M | Sell |
5,877,283
-11,444
| -0.2% | -$205K | 0.12% | 196 |
|
|
2015
Q3 | $96.6M | Buy |
5,888,727
+119,532
| +2% | +$2.04M | 0.12% | 201 |
|
|
2015
Q2 | $102M | Buy |
5,769,195
+138,476
| +2% | +$2.47M | 0.12% | 199 |
|
|
2015
Q1 | $100M | Sell |
5,630,719
-113,743
| -2% | -$1.8M | 0.12% | 207 |
|
|
2014
Q4 | $76.1M | Sell |
5,744,462
-168,090
| -3% | -$2.15M | 0.09% | 261 |
|
|
2014
Q3 | $69.8M | Sell |
5,912,552
-201,167
| -3% | -$2.53M | 0.08% | 266 |
|
|
2014
Q2 | $78.1M | Buy |
6,113,719
+44,973
| +0.7% | +$585K | 0.09% | 253 |
|
|
2014
Q1 | $82M | Sell |
6,068,746
-209,752
| -3% | -$2.75M | 0.1% | 233 |
|
|
2013
Q4 | $75.5M | Sell |
6,278,498
-72,964
| -1% | -$862K | 0.09% | 247 |
|
|
2013
Q3 | $74.6M | Sell |
6,351,462
-319,606
| -5% | -$3.46M | 0.1% | 239 |
|
|
2013
Q2 | $61.8M | Buy |
+6,671,068
| New | +$56.6M | 0.09% | 272 |
|
Other funds holding BSX
VCM
VPM
Legal & General Group's BSX Position: Q1 2026 in Review
Legal & General Group reduced its Boston Scientific (BSX) stake by 2.5% in Q1 2026, selling an estimated $22.1M and leaving 10,600,766 shares worth $665M. The position accounts for 0.15% of the portfolio, ranked #120.
Legal & General Group first reported a position in BSX in Q2 2013 and has held it in 52 quarters since. The position peaked at $1.1B in Q1 2025. 1,671 funds tracked by Wall St. Rank hold BSX as of Q1 2026.
- Legal & General Group held 10,600,766 shares of Boston Scientific worth $665M as of Q1 2026.
- Legal & General Group sold 275,851 Boston Scientific shares in Q1 2026, an estimated $22.1M.
- Boston Scientific made up 0.15% of Legal & General Group's portfolio in Q1 2026, its #120 holding.
- Legal & General Group first reported a position in Boston Scientific in Q2 2013 and has held it in 52 quarters since.
- Legal & General Group's Boston Scientific position peaked at $1.1B in Q1 2025.
- 1,671 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.
Based on Legal & General Group's 13F filing for Q1 2026, filed 8 May 2026.